英文摘要 |
Patients undergoing percutaneous coronary intervention (PCI) face a temporary cessation of antiplatelet medication, and oversight in reinstating this therapy upon discharge poses a substantial risk of stent thrombosis. This study aimed to mitigate physician negligence in prescribing antiplatelet medication post-PCI through information reminders, thereby reducing the risk of unforeseen stent thrombosis incidents. For patients with coronary artery disease who forgot to prescribe P2Y12 inhibitors post-percutaneous coronary intervention, four potential reasons were identified: (1) absence of reminder mechanisms during medication prescription at discharge, (2) rotating inpatient physicians unfamiliar with antiplatelet medications due to monthly unit changes, (3) lack of regular review meetings leading to cardiologists' unawareness of medication oversights, and (4) absence of reasons for medication non-prescription in medical records, hindering timely pharmacist oversight. Two strategic intervention groups were devised, involving the establishment of a post-percutaneous coronary intervention medication reminder system and the facilitation of regular team review meetings, aimed at achieving a 100% prescription rate of P2Y12 inhibitors at discharge. Following the implementation of a post-percutaneous coronary intervention medication reminder system and regular review meetings with the medical team, the prescription rate of P2Y12 inhibitors at discharge escalated from 97.4% to 100%. Moreover, there was a high level of user satisfaction with the system. The incorporation of a medication reminder system coupled with periodic review meetings proves to be an effective strategy in augmenting the prescription rates of antiplatelet medications post-percutaneous coronary intervention. |